Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Terminated NCT07061275

Telehealth-Supervised Resistance Training for Children With Cerebral Palsy

Conditions: Cerebral Palsy

Sex: All
Ages: 6 Years – 15 Years
Healthy volunteers: No
Phase: NA
Enrollment: 50
Sponsor: Hunan Normal University

Location: Hunan Normal University Changsha Hunan

Summary

The goal of this clinical trial is to evaluate the feasibility and potential benefits of telehealth-supervised resistance training in ambulatory children aged 6 to 15 years with cerebral palsy (CP) classified as Gross Motor Function Classification System (GMFCS) levels I-III. The main questions it aims to answer are: * Is a 12-week telehealth-delivered resistance training program feasible and acceptable for children with CP and their caregivers? * Can the program improve physical function and psychosocial well-being in this population? Participants will: * Take part in three 40-minute, live-streamed resistance training sessions each week for 12 weeks, using elastic bands, sandbag weights, and balance tools * Complete physical assessments before and after the program, including the 1-minute walk test, 10-meter walk test, 30-second sit-to-stand test, and Pediatric Balance Scale * Complete quality of life surveys using the Pediatric Quality of Life Inventory (PedsQL™ 3.0 CP Module) * Have caregivers complete a custom questionnaire about the cost and acceptability of the program

Eligibility Criteria

Inclusion Criteria: * No history of heart disease or family history of heart disease; * Children classified as GMFCS levels I, II, or III; * Dependent on assistive mobility devices, such as wheelchairs or posture support walkers, for activities of daily living; * Medically stable and able to sit upright for at least 30 minutes; * Able to understand simple verbal or visual instructions. Exclusion Criteria: * Aged under 6 years or over 15 years; * Received botulinum toxin A injections for lower limb muscles within six months prior to baseline assessment; * Implanted with an intrathecal baclofen pump, or has a history of lower limb-related orthopedic or neurosurgical interventions (such as tendon lengthening, osteotomy, or selective dorsal rhizotomy); * Has uncontrolled epilepsy, severe cognitive impairment, or other comorbidities.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07061275). StuddyBuddy aggregates publicly available trial information.